Page last updated: 2024-09-05

sorafenib and ctx-0294885

sorafenib has been researched along with ctx-0294885 in 1 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(ctx-0294885)
Trials
(ctx-0294885)
Recent Studies (post-2010) (ctx-0294885)
6,5207305,251505

Protein Interaction Comparison

ProteinTaxonomysorafenib (IC50)ctx-0294885 (IC50)
Mitogen-activated protein kinase 10Homo sapiens (human)0.37

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Abu Rabah, RR; Al Shamma, SA; Al-Tel, TH; Anbar, HS; El-Gamal, MI; Elgendy, SM; Omar, HA; Sebastian, A; Shehata, MK; Sultan, S; Tarazi, H; Vunnam, S; Zaraei, SO1

Other Studies

1 other study(ies) available for sorafenib and ctx-0294885

ArticleYear
Design, synthesis, and biological evaluation of a new series of pyrazole derivatives: Discovery of potent and selective JNK3 kinase inhibitors.
    Bioorganic & medicinal chemistry, 2022, 09-01, Volume: 69

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Design; Drug Screening Assays, Antitumor; Humans; Liver Neoplasms; Molecular Structure; Protein Kinase Inhibitors; Pyrazoles; Structure-Activity Relationship

2022